braf v600e mutation Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Memorial Sloan Kettering Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadbraf v600e

I am/have/hadbraf v600e mutation positive

I am/have/hadmeasurable disease

I am/have/hadcarcinoma

I am/have/hadplat

I am/have/hadgilbert's syndrome

I am/have/hadplatelet count

I am/have/hadfollicular thyroid cancer

I am/have/hadanticoagulation therapy

I am/have/hadexternal beam radiation therapy

I am/have/hadprimary tumor

I am/have/hadlipase

I am/have/hadpet/ct

I am/have/hadthyroid cancer, follicular

I am/have/hadneutrophil count

I am/have/hadtargeted therapy

I am/have/hadmetastasis

I am/have/hadcancer

I am/have/hadcoagulation therapy

I am/have/hadthyroid cancer

added new label for I am/have/had

more

I am looking for

I am looking fortotal bilirubin

I am looking forlipase

I am looking forcopanlisib

I am looking foravid

I am looking forvemurafenib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

The purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given …

braf v600e mutation positive

plat

carcinoma

gilbert's syndrome

vemurafenib

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.